📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Saliency

1.1 - Company Overview

Saliency Logo

Saliency

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medical imaging workflow automation for clinical trials, halving turnaround time for quality control, preparation of images for physician review, and image annotations. Solutions customized for imaging modality and therapeutic area.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Saliency

YPrime Logo

YPrime

HQ: United States Website
  • Description: Provider of eClinical solutions to expedite patient management, clinical supplies, and data in clinical trials, including IRT for patient randomization and drug supply management; eCOA for electronic collection of patient-, clinician-, and observer-reported outcomes; eConsent; patient engagement services and technologies; and clinical consulting to optimize processes, customize data collection, and integrate systems.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full YPrime company profile →
Unlearn Logo

Unlearn

HQ: United States Website
  • Description: Provider of AI, digital twin, and statistical methods to enable smaller, more efficient clinical trials, offering TwinRCTs (RCTs enhanced with AI-generated digital twins), Digital Twin Generators to predict individual health outcomes over time, regulatory services to navigate and meet FDA and EMA guidelines, and PROCOVA using prognostic scores from digital twins to enhance statistical power.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Unlearn company profile →
ScienceIO Logo

ScienceIO

HQ: United States Website
  • Description: Provider of a biomedical language platform and AI solutions that transform complex medical text into usable data and insights, detecting biomedical terms, clinical variables, and codes, linking concepts for powerful queries. Offers API access, patient cohorting, digital health message analysis, commercial landscaping, payor workflow digitization, and diagnostics & biomarkers for genomic-driven patient segmentation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ScienceIO company profile →
Owkin Logo

Owkin

HQ: United States Website
  • Description: Provider of AI precision medicine solutions to discover and develop cancer treatments. Offerings include MSIntuit CRC for MSI pre-screening in colorectal cancer, DrugMATCH for drug repositioning, TargetMATCH for target and subgroup discovery, Substra federated learning software, the MOSAIC oncology multiomics dataset, and AI diagnostics for pathology images. Uses AI to identify drug candidates and de-risk and accelerate clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Owkin company profile →
NiKang Therapeutics Logo

NiKang Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule oncology therapeutics, developing NKT2152, a HIF2α inhibitor in Phase 1/2 for clear cell renal cell carcinoma and other solid tumors; NKT3447, a reversible ATP-competitive CDK2 inhibitor in Phase 1 for solid tumors; KRAS G12D mutation inhibitors; and a SHP2 inhibitor being clinically evaluated by Erasca.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NiKang Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Saliency

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Saliency

2.2 - Growth funds investing in similar companies to Saliency

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Saliency

4.2 - Public trading comparable groups for Saliency

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Saliency

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Saliency

What does Saliency do?

Saliency is a provider of medical imaging workflow automation for clinical trials, halving turnaround time for quality control, preparation of images for physician review, and image annotations. Solutions customized for imaging modality and therapeutic area.

Who are Saliency's competitors?

Saliency's competitors and similar companies include YPrime, Unlearn, ScienceIO, Owkin, and NiKang Therapeutics.

Where is Saliency headquartered?

Saliency is headquartered in United States.

How many employees does Saliency have?

Saliency has 1,000 employees 🔒.

When was Saliency founded?

Saliency was founded in 2010 🔒.

What sector and industry vertical is Saliency in?

Saliency is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Saliency

Who are the top strategic acquirers in Saliency's sector and industry

Top strategic M&A buyers and acquirers in Saliency's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Saliency?

Top strategic M&A buyers groups and sectors for Saliency include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Saliency's sector and industry vertical

Which are the top PE firms investing in Saliency's sector and industry vertical?

Top PE firms investing in Saliency's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Saliency's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Saliency's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Saliency's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Saliency include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Saliency's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Saliency?

The key public trading comparables and valuation benchmarks for Saliency include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Saliency for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Saliency with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Saliency's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Saliency with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Saliency's' sector and industry vertical?

Access recent funding rounds and capital raises in Saliency's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Saliency